Each box includes 4 prefilled pens and 12 disposable pen needles.
The adjustable dose dial allows flexible dosing based on your individual needs,
with up to 12 injections per box.

Triple-Agonist Formula for More Powerful Weight Loss Retatrutide targets GLP-1, GIP, and Glucagon receptors simultaneously. This triple-agonist mechanism helps reduce appetite, improve blood sugar control,and increase energy expenditure,delivering greater weight-loss potential than previous-generation therapies.
In clinical studies, participants achieved an average weight loss of approximately 24%, with some individuals reaching up to 28% of their body weight.


Real Weight-Loss Results




{{commentStat.total}} Revirews



{{item.comments}}